Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
about
Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.Systematic review of drug administration costs and implications for biopharmaceutical manufacturing.Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.Golimumab: A Review in Inflammatory Arthritis.Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective.Golimumab: A Novel Anti-Tumor Necrosis Factor.
P2860
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@en
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@nl
type
label
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@en
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@nl
prefLabel
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@en
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@nl
P2093
P2860
P1476
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
@en
P2093
Ewen Cummins
Jacqueline Buchanan
Manishi Prasad
P2860
P2888
P304
P356
10.1007/S10198-011-0335-X
P577
2011-07-01T00:00:00Z